Downregulation of the purinergic receptors p2ry12/p2ry13, cx3cr1, and tmem119. Upregulation of AD risk factors (apoe, ctsd, lpl, tyrobp and trem2). This evidence concerns the gene P2RY12 and Alzheimer disease.